CA2244679C - Preparation contenant du tranilast pour application externe et methode de production de cette preparation - Google Patents

Preparation contenant du tranilast pour application externe et methode de production de cette preparation Download PDF

Info

Publication number
CA2244679C
CA2244679C CA 2244679 CA2244679A CA2244679C CA 2244679 C CA2244679 C CA 2244679C CA 2244679 CA2244679 CA 2244679 CA 2244679 A CA2244679 A CA 2244679A CA 2244679 C CA2244679 C CA 2244679C
Authority
CA
Canada
Prior art keywords
tranilast
preparation
external application
active ingredient
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2244679
Other languages
English (en)
Other versions
CA2244679A1 (fr
Inventor
Masao Mori
Noriyasu Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lead Chemical Co Ltd
Original Assignee
Lead Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Chemical Co Ltd filed Critical Lead Chemical Co Ltd
Priority claimed from PCT/JP1997/000283 external-priority patent/WO1997028793A1/fr
Publication of CA2244679A1 publication Critical patent/CA2244679A1/fr
Application granted granted Critical
Publication of CA2244679C publication Critical patent/CA2244679C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention concerne une composition à usage externe contenant du tranilast, laquelle possède d'excellentes qualités de libération du principe actif qu'elle contient, permet d'obtenir une absorption percutanée élevée, et assure pleinement une concentration efficace du médicament dans les tissus de la peau sans entraîner de trop grande irritation de cette dernière. Cette préparation se compose d'une base aqueuse qui comprend, en qualité de principe actif, du tranilast, un sel de celui-ci ou un mélange de ces derniers. Cette base aqueuse contient également un agent de solubilisation du tranilast, un agent de dispersion, un agent d'aide à l'absoprtion, un adhésif et/ou un agent de maintien de la forme et, enfin, de l'eau. Le principe actif est solubilisé à l'aide de l'agent de solubilisation susmentionné, puis dispersé dans la base aqueuse à l'aide dudit agent de dispersion.
CA 2244679 1996-02-07 1997-02-06 Preparation contenant du tranilast pour application externe et methode de production de cette preparation Expired - Fee Related CA2244679C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPHEI8-45493 1996-02-07
JP4549396 1996-02-07
PCT/JP1997/000283 WO1997028793A1 (fr) 1996-02-07 1997-02-06 Preparation a usage externe comprenant du tranilast et processus de production de cette preparation

Publications (2)

Publication Number Publication Date
CA2244679A1 CA2244679A1 (fr) 1997-08-14
CA2244679C true CA2244679C (fr) 2007-08-07

Family

ID=29422271

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2244679 Expired - Fee Related CA2244679C (fr) 1996-02-07 1997-02-06 Preparation contenant du tranilast pour application externe et methode de production de cette preparation

Country Status (1)

Country Link
CA (1) CA2244679C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844774B2 (en) 2014-04-24 2023-12-19 Omoidesouzou Co., Ltd. Amyloid fiber formation limiter or inhibitor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844774B2 (en) 2014-04-24 2023-12-19 Omoidesouzou Co., Ltd. Amyloid fiber formation limiter or inhibitor

Also Published As

Publication number Publication date
CA2244679A1 (fr) 1997-08-14

Similar Documents

Publication Publication Date Title
US6239177B1 (en) Tranilast-containing preparation for external application and method of producing the same
EP0947584B1 (fr) Preparation de Loxoprofen pour l'usage externe.
JP4181232B2 (ja) ジクロフェナクナトリウム含有油性外用貼付製剤
AU713461B2 (en) Preparation for percutaneous absorption
WO1996004902A1 (fr) Composition pour preparation a usage externe
MXPA02006454A (es) Formulacion anestesica local de base alcohol, y metodo para su uso.
EP1174132A1 (fr) Preparations a base d'oxybutynine destinees a etre absorbees par voie percutanee
KR20070059079A (ko) 경피 페로스피론 투여용 의약적 조성물
WO2005102306A1 (fr) Patch adhésif analgésique anti inflammatoire
CA2244679C (fr) Preparation contenant du tranilast pour application externe et methode de production de cette preparation
KR100552649B1 (ko) 펠비낙 함유 소염진통용 플라스터
JP2838297B2 (ja) コルヒチン含有外用剤
JP2001058961A (ja) 経皮吸収促進剤及び経皮吸収型製剤
JP3612731B2 (ja) 消炎鎮痛外用剤
KR20050077426A (ko) 비스테로이드성 소염진통제 함유 플라스터
JP2008231081A (ja) ケトプロフェン含有外用剤
JP2004123551A (ja) ケロイド等の形成抑制外用剤
RU2173145C2 (ru) Препарат для наружного применения, содержащий локсопрофен
JPS62187415A (ja) 経皮吸収促進用組成物
JP2009235065A (ja) 経皮吸収促進剤、並びにこれを含有する皮膚処理用製剤及び経皮吸収型製剤
JPH0624986A (ja) エペリゾンまたはその塩を含む経皮吸収製剤用組成物および経皮吸収製剤
JPH02174716A (ja) 経皮用製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed